Sarcopenia as a Risk Factor in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation

Laura Büttner1, Annette Aigner2, Regina Stegherr2

  • 1Department of Radiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Charitéplatz 1, 10117 Berlin, Germany.

Summary

Sarcopenia, a loss of muscle mass, is linked to worse outcomes after transjugular intrahepatic portosystemic shunt (TIPS) procedures. Identifying sarcopenia using CT scans can help predict complications and mortality in TIPS patients.